Considering that anxiety disorders frequently begin before adulthood and often result in chronic impairment, it is important to characterize the developmental pathways leading to the onset of clinical anxiety. Identifying neural biomarkers that can predict the onset of anxiety in childhood may increase our understanding of the etiopathogenesis of anxiety, as well as inform intervention and prevention strategies. An event-related potential (ERP), the error-related negativity (ERN), has been proposed as a biomarker of risk for anxiety and has previously been associated with anxiety in both adults and children. However, no previous study has examined whether the ERN can predict the onset of anxiety disorders. In the current study, ERPs were recorded while 236 healthy children, approximately 6 years of age, performed a go/no-go task to measure the ERN. Three years later, children and parents came back to the lab and completed diagnostic interviews regarding anxiety disorder status. Results indicated that enhanced error-related brain activity at age 6 predicted the onset of new anxiety disorders by age 9, even when controlling for baseline anxiety symptoms and maternal history of anxiety. Considering the potential utility of identifying early biomarkers of risk, this is a novel and important extension of previous work.
Anxiety disorders are one of the most common forms of psychopathology in both children and adults, and are associated with substantial impairment (Beesdo, Knappe, & Pine, 2009; Beesdo, Pine, Lieb, & Wittchen, 2010; Kessler et al., 2005; Last, Perrin, Hersen, & Kazdin, 1996) . Both retrospective and prospective studies have demonstrated that anxiety disorders frequently begin before adulthood and are moderately stable across the life span (Bittner et al., 2007; Copeland, Angold, Shanahan, & Costello, 2014; Kessler et al., 2005; Last et al., 1996; Pine, Cohen, Gurley, Brook, & Ma, 1998; Wittchen, Lieb, Pfister, & Schuster, 2000) . Considering that anxiety disorders often begin early in life and result in chronic impairment, it is important to map and understand the developmental pathways leading to anxiety disorders.
There is increasing research focus on core neural systems that might underlie clinical anxiety, and elucidating their development (Pine, 2007) . Identifying neural biomarkers that not only correlate with anxiety, but can predict the subsequent onset of anxiety disorders in childhood may be particularly important for understanding the etiopathogenesis of clinical anxiety. Reliable biomarkers of risk would have considerable implications for the implementation and development of intervention and prevention strategies.
An event-related potential (ERP), the error-related negativity (ERN), has been proposed as a biomarker of risk for anxiety (Hajcak, 2012; Proudfit, Inzlicht, & Mennin, 2013) . The ERN is a negative-going deflection in the ERP that occurs when participants make mistakes during a speeded response task (Falkenstein, Hohnsbein, Hoormann, & Blanke, 1991; Gehring, Goss, Coles, Meyer, & Donchin, 1993) . Within adult populations, many studies have documented an increased ERN in obsessive-compulsive disorder (OCD; Endrass, Klawohn, Schuster, & Kathmann, 2008; Gehring, Himle, & Nisenson, 2000; Stern et al., 2010; Xiao et al., 2011) and Weinberg, Olvet, & Hajcak, 2010; Xiao et al., 2011) . In one study, children with OCD continued to have an increased ERN even after successful treatment when symptom scores were below the clinical range (Hajcak, Franklin, Foa, & Simons, 2008) . In addition, unaffected individuals who have first-degree relatives with OCD are characterized by an increased ERN (Riesel, Endrass, Kaufmann, & Kathmann, 2011) , and this same pattern has recently been found in children (Carrasco et al., 2013) . Also, the ERN appears to be trait-likecharacterized by excellent test-retest reliability of up to 2 years in adults (Weinberg & Hajcak, 2011) and children (Meyer, Bress, & Proudfit, 2014) . Considering that the ERN has been shown to be between 45% and 60% heritable (Anokhin, Golosheykin, & Heath, 2008) , these findings collectively suggest that an increased ERN may be a heritable biomarker, or endophenotype, for anxiety (Hajcak, 2012; Manoach & Agam, 2013; Proudfit et al., 2013) , and may be useful in tracing developmental trajectories of risk.
Consistent with work in adults, previous cross-sectional research in developmental populations has found an increased ERN within a heterogeneous group of clinically anxious children and adolescents (Ladouceur, Dahl, Birmaher, Axelson, & Ryan, 2006) , children and adolescents with obsessive-compulsive disorder (Carrasco et al., 2013; Hajcak et al., 2008; Hanna et al., 2012) , and children as young as 6 years old with anxiety disorders (Meyer et al., 2013) . In addition, the relationship between the ERN and anxiety appears to be specific, for example, depression has been related to a blunted ERN in children (Ladouceur et al., 2012) .
Evidence from multiple source localization studies (Dehaene, Posner, & Don, 1994; Mathalon, Whitfield, & Ford, 2003; van Veen & Carter, 2002) , as well as studies that combine ERP and functional magnetic resonance imaging (fMRI; Debener et al., 2005) , suggest that the ERN is generated in the anterior cingulate cortex (ACC). The ACC is a region of the medial frontal cortex where information about pain, threat, and punishment is integrated to modify subsequent behavior (Shackman et al., 2011) . FMRI studies have also found increased error-related ACC activity among anxious individuals (Fitzgerald et al., 2005; Paulus, Hozack, Frank, & Brown, 2002; Ursu, Stenger, Shear, Jones, & Cameron, 2003) , and one study found that adolescents with generalized anxiety disorder showed greater activation in a network including the ACC in response to fearful faces (McClure, Monk, & Nelson, 2007) . We have proposed that a larger ERN among anxious individuals-and among those at risk for anxiety-may reflect the increased threat value of errors; that is, a larger ERN suggests that errors are more aversive for these individuals (Proudfit et al., 2013) . This proposal is consistent with data in which punishing errors potentiates the ERN in the lab (Riesel, Weinberg, Endrass, Kathmann, & Hajcak, 2012) , and recent work linking harsh parenting to a larger ERN in children .
We conceptualize errors as a specific type of threat-indeed, errors prompt a cascade of physiological and neural responses consistent with defensive mobilization (e.g., skin conductance response, heart rate deceleration, potentiated startle reflex, pupil dilation, corrugator muscle contraction, and amygdala activation; for review, see . This is consistent with the notion that error-related ACC activity reflects the need to exert control in the face of threat, punishment, or pain (Shackman et al., 2011) . Thus, we view variability in the ERN as reflecting individual differences in reactivity to an internal source of threat. During the transition from early to late childhood, normative anxiety tends to transition from fear of external threat (e.g., the dark, spiders, monsters) to self-conscious shyness and worry about behavioral competence and evaluation (i.e., internal threat and performance monitoring; Copeland et al., 2014; Gullone, 2000; Spence & McCathie, 1993; Spence, Rapee, McDonald, & Ingram, 2001; Vasey, Crnic, & Carter, 1994) . Similarly, the magnitude of the ERN begins to increase during the transition into late childhood (Tamnes, Walhovd, Torstveit, Sells, & Fjell, 2013) . A recent study found that negative life events specifically related to children's own behavior (e.g., conflicts with peers) have a greater impact on the likelihood of developing an anxiety disorder than external life events (e.g., natural disasters) in youth (Broeren, Newall, Dodd, Locker, & Hudson, 2014) , suggesting that internal sources of threat may be particularly relevant in the development of anxiety. Thus, we expect that children who are on a developmental trajectory toward the onset of an anxiety disorder may display an increased sensitivity to errors as an internal source of threat, reflected in a larger ERN. These children, characterized by an increased neural response to errors, may be more focused on their own competence and more sensitive to performance-based failures than typically developing youth, and thereby have a greater probability of developing clinical anxiety.
To our knowledge there are only two prospective studies that have examined the relation of the ERN to subsequent anxiety, both having found that among children high in early temperamental behavioral inhibition, an increased ERN predicted anxiety symptoms later in development (Lahat et al., 2014; McDermott et al., 2009) . This is important in that no study has yet controlled for baseline anxiety or examined whether the ERN can predict the onset of anxiety disorders.
In the current study, we sought to address this question and test whether an increased ERN would confer risk for subsequent anxiety disorders. ERPs were recorded while 236 healthy children, approximately 6 years of age, performed a go/no-go task to measure the ERN. Previous reports suggest that anxiety disorder status at age 6 related to a larger ERN (Meyer et al., 2013) . The current study focused only on those 6-year olds without anxiety disorder, and examined whether ERN would prospectively predict new anxiety diagnoses 3 years later. The ability of the ERN to predict anxiety disorder onset was examined in relation to, and controlling for, variables that have been previously linked to the ERN, especially current anxiety symptoms (Meyer, Weinberg, Klein, & Hajcak, 2012; Santesso, Segalowitz, & Schmidt, 2006) and maternal history of anxiety disorder (Meyer et al., 2013; Torpey et al., 2013) . We hypothesized that an enhanced ERN at age 6 would predict the onset of an anxiety disorder 3 years later. To examine specificity, we also investigated whether the ERN predicted new onsets of externalizing disorders.
Method

Participant Recruitment and Study Overview
Originally, participants were identified through a commercial mailing list. Eligible families had a child with no significant medical conditions or developmental disability, and at least one English-speaking biological parent. Of families who were eligible, 66.4% entered the study. Families who agreed and declined to participate did not differ significantly on child sex and race/ ethnicity and parental marital status, education, and employment status. Census data suggest the sample is reasonably representative of the surrounding county (Bufferd, Dougherty, Carlson, & Klein, 2011; Olino, Klein, Dyson, Rose, & Durbin, 2010 ). An initial assessment was completed when the children were approximately 3 years of age during which a parent (generally mothers) completed a diagnostic interview regarding their child, the Preschool Age Psychiatric Assessment, Version 1.4 (PAPA; Egger, Ascher, & Angold, 1999) . Mothers were also interviewed regarding their own histories of psychopathology using the Structured Clinical Interview for DSM-IV (SCID; First et al., 1995) .
Children returned to the lab 3 years later (i.e., around 6 years of age) and completed electroencephalography (EEG) tasks. During the age-6 assessment, the parent was readministered the PAPA and completed the Child Behavior Checklist (CBCL; Achenbach & Edelbrock, 1981) . Three years later, when children were approximately 9 years of age, parents and children completed a diagnostic interview, the Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS-PL; Kaufman et al., 1997) . At all assessments, after a description This document is copyrighted by the American Psychological Association or one of its allied publishers.
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of the study, written informed consent was obtained; all procedures were approved by the university's institutional review board.
Demographics
The original sample included 328 children with adequate ERP data collected when they were approximately 6 years of age (Torpey, Hajcak, Kim, Kujawa, & Klein, 2011) . Of these children, 85 met criteria for a current Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2013) diagnosis at the age-6 assessment, and were excluded from all subsequent analyses: 48 for any anxiety disorder, 18 for attention deficit/hyperactivity disorder, 31 for oppositional defiant disorder, and 17 for a depressive disorder (Meyer et al., 2013) .
Of the remaining 243 children, 236 had adequate diagnostic data from the age-9 assessment. Of these 236 children (109 female), 26 met criteria for the onset of a new anxiety disorder between the ages of 6 and 9 (ANX) and 210 did not develop an anxiety disorder (No ANX). Overall, 95.8% of the children were White, 2.3% Asian, 0.5% Hispanic, and 1.4% identified as Other. The average age during the age-6 assessment was 6.11, SD ϭ .43; during the age-9 assessment, it was 9.21, SD ϭ .45.
Diagnostic and Symptom Measures
PAPA. The PAPA assesses a range of disorders from the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV; APA, 1994) in preschool-age children (Egger et al., 1999) . DSM-IV diagnoses were derived using algorithms made by the developers of the instrument. Symptoms occurring within the 3 months prior to the interview are rated to maximize recall. The interview has been shown to have good psychometric properties (Egger et al., 2006) . Interviews were conducted by master's level psychologists over the telephone at age 3 and face to face with parents at age 6. Based on 35 audio-taped interviews, randomly selected: at age 3, s were 1.00 for all diagnostic categories, and at age 6, they were .64 for depression, .89 for any anxiety disorder, .64 for attention deficit/hyperactivity disorder, and .87 for oppositional defiant disorder. More detailed information on the rates of psychiatric disorders in this sample have been reported elsewhere (Bufferd, Dougherty, Carlson, Rose, & Klein, 2012) .
K-SADS-PL. The K-SADS-PL (Kaufman et al., 1997) , modified for DSM-IV (APA, 1994), was administered by a master's level interviewer with extensive clinical experience and clinical psychology graduate students in video-recorded, face-to-face interviews with both a parent (generally the mother) and the child. The K-SADS is designed to assess a range of psychopathology in children and adolescents (Kaufman et al., 1997) . Lifetime DSM-IV diagnoses were derived from a combination of the parent and child reports and if discrepancies arose, the interviewer attempted to reconcile them with the parent and child at the end of the interview. All diagnoses were reviewed in case conferences led by an experienced child psychiatrist and a clinical psychologist. Reliability ratings were performed by the interviewers based on 74 randomly selected videotaped interviews; the for any anxiety disorder was .67. At the age-9 assessment, 26 children met criteria for a new anxiety disorder (with an onset between the ages of 6 and 9): six for social phobia, 12 for specific phobia, five for generalized anxiety disorder, and three for anxiety disorder not otherwise specified (NOS).
1 In addition, 19 children met criteria for a new externalizing disorder: three for oppositional defiant disorder, eight for attention deficit hyperactivity disorder, six for attention deficit hyperactivity disorder NOS, and two for comorbid oppositional defiant disorder and attention deficit hyperactivity disorder.
SCID. Lifetime maternal anxiety was assessed with the SCID (First et al., 1995) by master's level psychologists during the age-3 assessment. Interviews were conducted over the telephone and interrater reliabilities for the presence or absence of a lifetime anxiety disorder was .91 (for details, see Torpey et al., 2013) . Consistent with lifetime prevalence rates from the National Comorbidity Survey (Kessler et al., 2005) , in the current sample, 73 mothers (30.9%) had a history of an anxiety disorder.
CBCL. Previous studies have found an association between anxiety symptoms and the ERN in children (Meyer, Weinberg, et al., 2012; Santesso et al., 2006) . To control for children's prior anxiety symptoms at age 6, we used the DSM-IV (APA, 1994) Anxiety Problems subscale derived from the CBCL (Achenbach & Edelbrock, 1981) . The Anxiety Problems subscale consists of six items that are rated for the past 6 months on a scale from 0 (not true) to 2 (very or often true). In the current sample, coefficient ␣ was .65, and the mean score was .79, SD ϭ 1.07, with a range of 0 -6. From here on, anxiety symptoms refer to those measured by the CBCL at age 6. For follow-up analyses, we also used the age-6 CBCL Externalizing scale, ranging from 0 to 21, with a mean of 3.74, SD ϭ 3.91, as well as the age-9 CBCL Anxiety and Externalizing scales, M ϭ .95, SD ϭ 1.4, and M ϭ 3.39, SD ϭ 3.82, respectively.
EEG Task and Materials
As previously reported (Meyer et al., 2013; Torpey et al., 2011) , a go/no-go task was administered using Presentation software (Neurobehavioral Systems, Berkeley, CA). The stimuli were green equilateral triangles in four orientations: During 60% of trials, the triangles were vertically aligned and pointed up; on 20% of the trials, the triangles were vertically aligned and pointed down; on 10% of the trials, the triangles were tilted slightly to the left; and on 10% of the trials, the triangles were tilted slightly to the right. Children were instructed to respond to upward-pointing triangles by pressing a mouse button, and to withhold a response to all other triangles.
Psychophysiological Recording
The Active Two System (Biosemi, Amsterdam, the Netherlands) was used to acquire EEG data. Thirty-two electrodes were used with a small amount of electrolyte, Signa Gel (Bio-Medical Instruments, Warren, MI), applied at each electrode position. Data were processed offline with Brain Vision Analyzer (Brain Products, Gilching, Germany). EEG data were referenced to the nose, and high and low pass were filtered at .1 and 30 Hz, respectively. Segments were extracted from the continuous EEG, beginning 500 ms prior to responses. ERP data were corrected for eye movements and blinks using the Gratton, Coles, and Donchin (1983) method. Artifacts were automatically rejected if a voltage step of more than 50 microvolts (V) between data points occurred, or if a voltage difference of less than .5 V within a 100-ms interval occurred. After this, data were visually inspected for remaining artifacts. ERP averages were created for each trial type (error and correct) and a baseline of the average activity from Ϫ500 to Ϫ300 ms prior to the response was subtracted from each data point.
ERP and behavioral results have been previously reported in the full sample (Meyer et al., 2013; Torpey et al., 2011; Torpey et al., 2013) . The ERN and correct-related negativity (CRN) were scored as the average voltage in the window from 0 to 100 ms after the response, at electrodes Fz, Cz, and Pz. The ⌬ERN was calculated by subtracting the CRN from the ERN. Behavioral measures included the number of errors of omission and commission, as well as average reaction times (RTs) on error and correct trials. RTs on correct trials that followed error trials were calculated to evaluate posterror RT slowing.
All statistical analyses were conducted using SPSS (Version 17.0) General Linear Model Software, with Greenhouse-Geisser correction applied to p values with multiple df when violation of the assumption of sphericity necessitated it. Repeated-measures ANOVAs and t tests were used to examine behavioral data. A repeated measures ANOVA was conducted with response type (error vs. correct) and electrode (Fz, Cz, and Pz) as within-subject variables and child anxiety disorder at age 9 (ANX or no ANX) as the between-subjects variable, controlling for age-6 CBCL DSM-IV Anxiety Problems, maternal history of anxiety (lifetime disorder or no disorder), and age 9 externalizing disorders (disorder or no disorder). Based on these results, we conducted a follow-up, simultaneous binary, logistic regression to examine whether the ⌬ERN uniquely predicted the onset of anxiety disorders when maternal history of anxiety and child anxiety symptoms at age 6 were considered. In addition, as a follow-up analysis, we conducted a simultaneous multiple regression in which age-6 ⌬ERN, maternal history of anxiety, and age-6 CBCL Anxiety symptoms were all entered to predict age-9 CBCL Anxiety symptoms.
Results
Behavioral Data
Accuracy and RT data are presented in Table 1 for the ANX and no-ANX groups. Overall, children were faster on error trials than on correct trials, F(1, 232) ϭ 97.03, p Ͻ .001, p 2 ϭ .30. The ANX and no-ANX groups did not differ in RT, F(1, 232) ϭ .50, p ϭ .48, nor did the effect of trial type vary by diagnostic status, F(1, 232) ϭ .22, p ϭ .22. Also, the ANX and no-ANX groups made a comparable number of errors, t(234) ϭ Ϫ.83, p ϭ .41 and correct responses, t(234) ϭ .93, p ϭ .36.
Posterror RT are also presented in Table 1 . Overall, children were slower on go trials that occurred after an error trial than the average of all go trials, F(1, 232) ϭ 7.34, p Ͻ .05, p 2 ϭ .03, but this effect did not vary by diagnostic group, F(1, 232) ϭ .45, p ϭ .50.
Error-Related Brain Activity
Figure 1 presents topographic maps on the right for the ANX (top) and no-ANX (bottom) groups, depicting voltage differences (in V) across the scalp for the ⌬ERN at age 6. Grand average response-locked ERPs are also presented in Figure 1 (left). Average ERN, CRN, and ⌬ERN values for the ANX and no-ANX group are presented in Table 1 .
Overall, the ERP response was more negative following errors than correct responses, F(1, 231) ϭ 84.42, p Ͻ .001, p 2 ϭ .27. There was no overall difference between the ANX and no-ANX groups, F(1, 231) ϭ .08, p ϭ .77. However, there was a significant three-way interaction between response, electrode, and anxiety group, F(2, 462) ϭ 4.51, p Ͻ .05, p 2 ϭ .02. In a follow-up repeated-measures ANOVA examining only the ERN, there was a significant interaction between electrode and anxiety group, F(2, 460) ϭ 3.26, p Ͻ .05. However, none of the follow-up ANOVAs suggested that the ERN alone differed between the ANX and no-ANX groups at any electrode (all ps Ͼ .1). In a repeatedmeasures ANOVA using only the CRN, the interaction between electrode and anxiety was not significant, F(2, 460) ϭ 1.25, p ϭ .28.
To probe the Response ϫ Condition interaction, we used the ⌬ERN. Confirming the impression from Figure 1 , a follow-up ANOVA suggested that children who would develop an anxiety disorder by age 9 had a larger ⌬ERN at Fz than children who would not develop any anxiety disorder, F(1, 231) ϭ 4.14, p Ͻ .05, p 2 ϭ .02. The ⌬ERN did not differ between the ANX and no-ANX group at Pz or Cz, all ps Ͼ .30.
Alternatively, we used pairwise t tests to compare the ⌬ERN at each electrode within the ANX and no-ANX groups. In the no- (Meyer et al., 2013; Torpey et al., 2013) , offspring of mothers with a history of anxiety disorder were characterized by a blunted ⌬ERN, F(1, 232) ϭ 2.49, p ϭ .09, p 2 ϭ .02, at a trend level. However, child anxiety symptoms at age 6 did not relate to the ⌬ERN, F(1, 232) ϭ 2.46, p ϭ .12. In addition, children who developed any externalizing disorder by age 9 were not characterized by an enhanced or blunted ⌬ERN at age 6, F(1, 231) ϭ 1.01, p ϭ .32. Levene's test indicated equal variances in the ⌬ERN at Fz between the ANX and no-ANX group, F ϭ .49, p ϭ .49.
As a follow-up analysis, to further investigate the specificity of the ⌬ERN to anxiety, we conducted a repeated measures ANOVA with response type (error vs. correct) and electrode (Fz, Cz, and Pz) as within-subject variables and child externalizing disorder at age 9 (externalizing diagnosis or not) as the between-subjects variable, controlling for age 6 CBCL Externalizing symptoms.
Again, the results suggested that age 6 ⌬ERN was not related to the onset of externalizing disorders, F(2, 442) ϭ 1.11, p ϭ .32.
Based on the findings from Lahat et al. (2014) and McDermott et al. (2009) regarding temperamental BI, we examined whether the ⌬ERN might interact with anxiety symptoms at age 6 to predict the onset of anxiety disorders by age 9. The interaction reached a trend level of significance: among children with a larger ⌬ERN, anxiety symptoms predicted the onset of an anxiety disorder, and this same pattern was not present in children with a relatively smaller ⌬ERN 
Predicting the Onset of Anxiety Disorders
The results of a logistic regression suggested that enhanced child anxiety symptoms at age 6 predicted the onset of a child anxiety disorder by age 9, R 2 ϭ .05, 2 ϭ 6.17, OR ϭ 1.52 [1.11, 2.10], p Ͻ .01. Furthermore, there was an association between maternal lifetime anxiety disorder and the onset of child anxiety by age 9, 2 (1) ϭ 3.58, p ϭ .06, at a trend level. To examine the unique ability of these factors to predict new anxiety disorder diagnoses by age 9, maternal anxiety disorder, child anxiety symptoms, and the ⌬ERN (at Fz) were all entered as predictors in a logistic regression. Results confirmed that maternal anxiety was a predictor at a trend level, and both child anxiety symptoms and the Figure 1 . On the left, response-locked ERP waveforms for correct and error trials, as well as the difference waves (top ϭ ANX group, bottom ϭ no-ANX group). On the right, topographic maps of activity (error minus correct; top ϭ ANX group, bottom ϭ no-ANX group). See the online article for the color version of this figure.
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⌬ERN uniquely predicted the onset of an anxiety disorder by age 9 (see Table 2 ). To examine anxiety symptoms rather than disorders as an outcome, we entered age-6 ⌬ERN, maternal history of anxiety, and age 6 CBCL Anxiety symptoms (Achenbach & Edelbrock, 1981) into a simultaneous regression predicting age 9 CBCL Anxiety symptoms. Results indicated that the ⌬ERN did not predict an increase in symptoms, p Ͼ .5.
Discussion
This is the first study to demonstrate that enhanced error-related brain activity precedes the onset of anxiety disorders. Increased error-related brain activity at age 6 predicted the onset of new anxiety disorders by age 9, even when controlling for baseline anxiety symptoms and maternal history of anxiety. There were no observable behavioral differences between the children who would become anxious and the rest of the sample, suggesting that enhanced error processing in the ANX group did not reflect performance-related differences. Moreover, the ERN did not predict the onset of externalizing disorders, suggesting that the ERN may specifically predict anxious trajectories-although future work is needed to examine the specificity of the ERN with respect to internalizing disorders (e.g., anxiety vs. depression). Follow-up analyses suggested that the pattern of results was the same after controlling for ages 6 and 9 depression symptoms, and that the ERN did not predict a change in depression symptoms. Considering the potential utility of identifying early biomarkers of risk, this is a novel and important extension of previous work that has linked concurrent anxiety and an increased ERN (Carrasco et al., 2013; Hajcak et al., 2008; Ladouceur et al., 2006; Meyer et al., 2013; Meyer, Weinberg, et al., 2012) .
Considering that the ⌬ERN is (a) elevated in children with OCD after successful treatment , (b) increased in unaffected first-degree relatives (Carrasco et al., 2013; Riesel et al., 2011) , (c) relatively stable across development (Meyer, Bress, et al., 2014), and, (d) in the present study, increased in children before the onset of anxiety disorders, the ⌬ERN may be a biomarker of risk for anxiety. In addition, because the ⌬ERN has been shown to be heritable (Anokhin et al., 2008) and linked to a number of specific genetic polymorphisms (Manoach & Agam, 2013; in this sample: Meyer, Klein, et al., 2012) , it has been proposed as a potential endophenotype for anxiety disorders (Manoach & Agam, 2013; Olvet & Hajcak, 2008; Proudfit et al., 2013) . To our knowledge, these are the first data to suggest that an increased ⌬ERN predicts later anxiety disorders, controlling for initial symptoms. The ⌬ERN may facilitate early identification of at-risk youth, contribute to the detection of further susceptibility genes, increase our understanding of the mechanisms of illness, and aid in the development of novel targets for early intervention (Gottesman & Gould, 2003; Manoach & Agam, 2013) .
In addition, results suggested there were topographical differences in the distribution of the ⌬ERN between the ANX and no-ANX groups. Although the overall ⌬ERN was largest at Cz, the ⌬ERN at Fz was larger among children who would become anxious compared with those who did not. And, in the no-ANX group, the ⌬ERN had a more parietal distribution (i.e., more negative at Pz than Fz) than the ⌬ERN in the ANX group. Overall, children in the ANX group had a more frontally distributed ⌬ERN, and this is where risk differentiated error-related brain activity.
The results from the current investigation are consistent with the notion that the ERN may index sensitivity to internal threat that is enhanced before the onset of an anxiety disorder. Children who were characterized by an increased ERN may have been developmentally advanced, relative to peers, in terms of transitioning from external fears to anxiety and concern about behavioral competence and increased performance monitoring. In line with previous work suggesting that error-related ACC activity increases normatively across development (Tamnes et al., 2013) , children who go on to develop anxiety disorders may be characterized by greater (i.e., larger and more frontal) sensitivity to errors. Also, many of the children in the current study were characterized by phobic disorders at age 9, and previous developmental work found that 73% of children diagnosed with a specific phobia met criteria for an anxiety or depressive disorder 10 years later (Emmelkamp & Wittchen, 2009) , which suggests that childhood phobias may mark pathological trajectories. Future work is needed to further examine these developmental trajectories.
To our knowledge, only one other study has reported on a biomarker that predicted risk for anxiety, finding that elevated startle during a safe condition predicted the onset of anxiety disorders over the course of 3-4 years in adolescents and young adults (Craske et al., 2012 ). In the current study, 10% of the variance in the onset of anxiety between the ages of 6 and 9 was accounted for by age-6 symptoms, ⌬ERN, and maternal history of anxiety. However, the children are still very young. As more cases accumulate over time, effect sizes may increase. Also, future researchers could investigate these risk factors in conjunction with other EEG or fMRI neural markers, parenting style, life stress, genes, cognitive vulnerabilities, executive functioning, cortisol reactivity, startle, attentional biases, socioeconomic status, temperament, fear learning, peer functioning, or family conflict to identify risk signatures (i.e., patterns or constellations of risk markers) that may increase our ability to predict the onset of clinical anxiety.
In addition to the ⌬ERN, maternal history of anxiety predicted the onset of anxiety disorders in children at a trend level. However, maternal history of anxiety was related at a trend level to a smaller ⌬ERN, consistent with previous findings in this sample (Meyer et al., 2013) . Thus, maternal history of anxiety appears to relate to child anxiety risk via mechanisms other than error-related brain activity. This may be due, in part, to maternal anxiety being a nonspecific risk factor that also predicts disorders associated with decreased error processing, that is, depression and externalizing This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
disorders (Beidel & Turner, 1997; Bijl, Cuijpers, & Smit, 2002; Merikangas, Dierker, & Szatmari, 1998) . Future researchers might further explore the mechanisms underlying these associations. In addition, the ⌬ERN did not predict age-9 CBCL Anxiety symptoms (Achenbach & Edelbrock, 1981) . This finding is generally consistent with our previous work, which suggests that dimensional anxiety symptoms in nonclinical populations only begin to relate to an increased ERN in later childhood (Meyer et al., 2013; Torpey et al., 2013; . Previous researchers have suggested that, among children high in early temperamental behavioral inhibition, an increased ERN predicted anxiety symptoms later in development (Lahat et al., 2014; McDermott et al., 2009) . Results from the current study are consistent with this-among children with an increased ⌬ERN at age 6, anxiety symptoms predicted the onset of anxiety disorders at a trend level. Future work is needed to further examine the relationship between normative levels of anxiety and the ERN across development.
A limitation of the current investigation is that anxiety disorders at age 9 were heterogeneous (i.e., included specific phobia, separation anxiety disorder, social phobia, generalized anxiety disorder, and anxiety NOS). Because the number of children with any particular disorder was small, we were unable to examine whether the ⌬ERN predicted the onset of specific anxiety disorders. Along with this, we attempted to examine specificity by conducting analyses regarding the onset of externalizing disorders. Although examining the onset of near-neighbor disorders such as depression would provide the strongest test of specificity (Garber & Hollon, 1991) , the incidence of depression during this developmental period is quite low. Indeed, only one child in our sample developed a new depressive disorder between the ages of 6 and 9. In addition, the current study was limited in age range (i.e., only 5-to 7-year olds were assessed for ERN). It is possible that the relationship between ⌬ERN and risk for anxiety changes across development. For example, it is possible that increased error-related brain activity precedes the onset of anxiety disorders in early childhood, but not in adolescence or adulthood. We are continuing to collect longitudinal data from the current sample to investigate this issue. In addition, given that 96% of the sample was White, future studies should explore whether the current findings are generalizable to more diverse populations. A final limitation to consider is that the PAPA at age 6 assessed symptoms within the preceding 3 months. While children with anxiety disorders occurring before 6 years of age, as reported at the age 9 K-SADS-PL (Kaufman et al., 1997) were excluded from the analyses, it is possible that retrospective reporting was not entirely accurate. Therefore, some of the children with an enhanced ERN at age 6 may have previously had anxiety disorders. Future longitudinal work should replicate and extend the current findings by assessing lifetime anxiety diagnoses at baseline.
An intriguing possibility is that error-related brain activity might be a novel target for treatment and prevention efforts. Among children who become anxious, the ⌬ERN is enhanced early in development, before children meet criteria for clinical anxiety disorders-thereby providing a novel and potentially malleable target for prevention. Anxiety treatments that target symptoms (i.e., cognitive-behavioral therapy) do not seem to impact the ERN , but findings suggest that environmental influences that more directly relate to error sensitivity (e.g., punishment) may impact the ERN. A previous study revealed that punishment for errors in the lab increased the ERN-an effect that persists after punishment ends . Similarly, both observed and self-reported harsh parenting is related to an increased ⌬ERN in children, and the magnitude of the ⌬ERN mediated the relationship between harsh parenting and anxiety disorders in children . Thus, interventions that decrease harsh or critical parenting (or even more general success or failure experiences) may impact the ⌬ERN and decrease the likelihood of anxiety disorders. Future studies might explore other ways in which the ⌬ERN can be modified, and the degree to which modifying the ERN reduces the likelihood of developing anxiety disorders in early childhood.
